Thus,IDH-mutated grade 4 gliomas were classified as a separatecategory of GBM in the World Health Organization 2016 Classification of Tumors ofthe Central Nervous System and as astrocytomas in the 2021 update. This evidence concerns the gene IDH2 and central nervous system cancer.